For fiscal 2026 (ended Mar 31, 2026), Infosys Limited reported $20.16B of revenue and $3.31B of net income.
INFY revenue was $20.16B for fiscal 2026 (ended Mar 31, 2026), up 4.6% from fiscal 2025. Compound annual growth was +8.3% over 5 years and +7.8% over 10 years. It rose in each of the last 10 fiscal years. Fiscal 2026 is the highest of the 11 fiscal years on file.
INFY net income was $3.31B for fiscal 2026 (ended Mar 31, 2026), up 4.9% from fiscal 2025. Compound annual growth was +4.9% over 5 years and +4.9% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2026 is the highest of the 11 fiscal years on file.
INFY diluted EPS was $0.80 for fiscal 2026 (ended Mar 31, 2026), up 5.3% from fiscal 2025. Compound annual growth was +5.6% over 5 years and +5.9% over 10 years.
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.16B | $19.28B | $18.56B | $18.21B | $16.31B | $13.56B | $12.78B | $11.80B | $10.94B | $10.21B |
| Cost of revenue | $14.08B | $13.40B | $12.97B | $12.71B | $11.00B | $8.83B | $8.55B | $7.69B | $7.00B | $6.45B |
| Gross profit | $6.08B | $5.87B | $5.59B | $5.50B | $5.32B | $4.73B | $4.23B | $4.11B | $3.94B | $3.76B |
| Research and development | $207.00M | $153.00M | $135.00M | $129.00M | $124.00M | $127.00M | $117.00M | $110.00M | $116.00M | $118.00M |
| Selling, general and admin | $969.00M | $903.00M | $911.00M | $902.00M | $868.00M | $784.00M | $840.00M | $778.00M | $727.00M | $707.00M |
| Operating income | $4.08B | $4.07B | $3.83B | $3.83B | $3.75B | $3.33B | $2.72B | $2.70B | $2.66B | $2.52B |
| Interest expense | $47.00M | $49.00M | $56.00M | $35.00M | $27.00M | $26.00M | $24.00M | - | - | - |
| Pre-tax income | $4.51B | $4.45B | $4.35B | $4.13B | $4.04B | $3.60B | $3.10B | $3.00B | $3.14B | $2.97B |
| Income tax | $1.19B | $1.28B | $1.18B | $1.14B | $1.07B | $973.00M | $757.00M | $803.00M | $657.00M | $834.00M |
| Net income | $3.31B | $3.16B | $3.17B | $2.98B | $2.96B | $2.61B | $2.33B | $2.20B | $2.49B | $2.14B |
| EPS, basic | $0.81 | $0.76 | $0.77 | $0.71 | $0.70 | $0.62 | $0.55 | $0.51 | $0.55 | $0.47 |
| EPS, diluted | $0.80 | $0.76 | $0.76 | $0.71 | $0.70 | $0.61 | $0.55 | $0.51 | $0.55 | $0.47 |
| Diluted shares | 4.12B | 4.15B | 4.14B | 4.19B | 4.22B | 4.25B | 4.27B | 4.35B | 4.52B | 4.57B |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.34B | $2.86B | $1.77B | $1.48B | $2.31B | $3.38B | $2.46B | $2.83B | $3.05B | $3.49B |
| Current assets | $10.91B | $11.36B | $10.72B | $8.63B | $8.87B | $8.31B | $7.21B | $7.64B | $7.67B | $8.28B |
| Goodwill | $1.28B | $1.18B | $875.00M | $882.00M | $817.00M | $832.00M | $699.00M | $512.00M | $339.00M | $563.00M |
| Total assets | $16.45B | $17.42B | $16.52B | $15.31B | $15.55B | $14.82B | $12.26B | $12.25B | $12.26B | $12.85B |
| Current liabilities | $5.52B | $5.01B | $4.65B | $4.77B | $4.43B | $3.26B | $2.76B | $2.69B | $2.16B | $2.16B |
| Total debt | - | - | - | - | - | - | - | - | $0 | - |
| Total liabilities | $6.61B | $6.16B | $5.92B | $6.09B | $5.56B | $4.32B | $3.56B | $2.85B | $2.29B | $2.22B |
| Shareholders' equity | $9.79B | $11.21B | $10.61B | $9.22B | $9.99B | $10.50B | $8.70B | $9.40B | $9.96B | $10.64B |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.04B | $4.35B | $3.15B | $2.85B | $3.35B | $3.26B | $2.61B | $2.26B | $2.26B | $2.10B |
| Capital expenditures | - | - | - | - | - | - | $465.00M | $349.00M | $310.00M | $411.00M |
| Free cash flow | - | - | - | - | - | - | $2.15B | $1.91B | $1.95B | $1.69B |
| Investing cash flow | $10.00M | -$361.00M | -$708.00M | -$218.00M | -$1.00B | -$1.13B | -$242.00M | -$225.00M | $482.00M | -$2.55B |
| Financing cash flow | -$4.49B | -$2.88B | -$2.12B | -$3.29B | -$3.33B | -$1.32B | -$2.51B | -$2.07B | -$3.20B | -$1.03B |
| Dividends paid | $2.13B | $2.42B | $1.78B | $1.70B | $1.70B | $1.23B | $1.36B | $1.96B | $1.16B | $1.03B |
| Share repurchases | $2.01B | - | - | $1.40B | $1.50B | - | $1.07B | $118.00M | $2.04B | - |
| Stock-based compensation | $108.00M | $95.00M | $79.00M | $64.00M | $56.00M | $45.00M | $34.00M | $29.00M | $13.00M | $17.00M |
| Depreciation and amortization | $552.00M | $569.00M | $565.00M | $524.00M | $466.00M | $441.00M | $407.00M | $287.00M | $289.00M | $254.00M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 4.6% | 3.9% | 1.9% | 11.7% | 20.3% | 6.1% | 8.3% | 7.9% | 7.2% | 7.4% |
| Net income growth, YoY | 4.9% | -0.3% | 6.2% | 0.6% | 13.4% | 12.1% | 6.0% | -11.5% | 16.2% | 4.3% |
| EPS growth, YoY | 5.3% | 0.0% | 7.0% | 1.4% | 14.8% | 10.9% | 7.8% | -7.3% | 17.0% | 4.4% |
| Gross margin | 30.2% | 30.5% | 30.1% | 30.2% | 32.6% | 34.9% | 33.1% | 34.9% | 36.0% | 36.9% |
| Operating margin | 20.3% | 21.1% | 20.7% | 21.0% | 23.0% | 24.5% | 21.3% | 22.8% | 24.3% | 24.7% |
| Net margin | 16.4% | 16.4% | 17.1% | 16.4% | 18.2% | 19.3% | 18.2% | 18.6% | 22.7% | 21.0% |
| Free cash flow margin | - | - | - | - | - | - | 16.8% | 16.2% | 17.8% | 16.5% |
| Return on equity | 33.9% | 28.2% | 29.9% | 32.3% | 29.6% | 24.9% | 26.8% | 23.4% | 25.0% | 20.1% |
| Return on assets | 20.1% | 18.1% | 19.2% | 19.5% | 19.0% | 17.6% | 19.0% | 17.9% | 20.3% | 16.6% |
| Current ratio | 1.98 | 2.27 | 2.31 | 1.81 | 2.00 | 2.55 | 2.62 | 2.84 | 3.55 | 3.83 |
| Debt to equity | - | - | - | - | - | - | - | - | 0.00 | - |
Source: XBRL data Infosys Limited files with the SEC, latest filing dated Jun 15, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 2-for-1, first reported Jun 19, 2019.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| INFY | $20.16B | +4.6% | $3.31B | 16.4% | $50.70B |
| ACN | $74.18B | +6.5% | $8.37B | 11.3% | $174.20B |
| CTSH | $21.89B | +5.0% | $2.57B | 11.8% | $28.93B |
| WIT | ₹926.24B | +4.0% | ₹131.97B | 14.2% | $21.39B |